Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 17.00
+1.99 (13.26%)
Jan 23, 2026, 3:00 PM CST
Novogene Employees
Novogene had 2,190 employees as of June 30, 2025. The number of employees decreased by 12 or -0.54% since the number was reported on December 31, 2024.
Employees
2,190
Change
-12
Growth
-0.54%
Revenue / Employee
986.77K CNY
Profits / Employee
79.57K CNY
Market Cap
6.08B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 2,190 | -12 | -0.54% |
| Dec 31, 2024 | 2,202 | 58 | 2.71% |
| Dec 31, 2023 | 2,144 | -25 | -1.15% |
| Dec 31, 2021 | 2,169 | 178 | 8.94% |
| Dec 31, 2020 | 1,991 | -584 | -22.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,769 |
| R&G PharmaStudies | 2,208 |
| Beijing Bohui Innovation Biotechnology Group | 2,179 |
| PharmaResources (Shanghai) | 1,085 |
| Wuhan Hvsen Biotechnology | 1,028 |
| Kexing Biopharm | 947 |
| Lifecome Biochemistry | 898 |
| Shenzhen Weiguang Biological Products | 859 |